Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
1.
Waste Manag ; 170: 240-251, 2023 Oct 01.
Article in English | MEDLINE | ID: mdl-37725856

ABSTRACT

Pig breeding is moving toward more intensive development and is accompanied by the integrated generation of pig waste. This has disrupted the synergy between the original manure and sewage management mode and corresponding farmland at the household level. Centralized bio-energy mode is proposed to relieve environmental pressure, increase the resource recovery efficiency and rebuild the breeding and cropping. However, there is a lack of comprehensive information on a regional scale, particularly regarding evaluation, applicability and feasibility. Therefore, compared to the individual and traditional mode at the household level, this study was conducted using life cycle assessment and life cycle cost analysis, systematically assessed the environmental performance and economic viability of the centralized bio-energy mode at the regional scale, and further explored the adaptability of multi-subjects (various pig farms and biogas enterprise) and regional feasibility. Results revealed that the centralized bio-energy mode appeared to be a better alternative in terms of global warming, terrestrial acidification and marine eutrophication, with the significant reductions of 49.49 %, 6.8 % and 4.67 % respectively. Moreover, the study demonstrated a substantial profit of 48.5 CNY1 per ton of managed pig waste. Furthermore, both environmental and economic performance could be improved through scale expansion and transport optimization, with an optimal collection radius of less than 31.45 km. Conclusions clarified the potential of centralized bio-energy mode and provided valuable references for its implementation in various regions. Ultimately, further contributing to a more efficient, cost-effective, and regulated manner for resource recovery, culminating in the sustainability of pig farming and achieving environmental-friendly agriculture practices in regional contexts.

2.
Eur J Pharm Biopharm ; 191: 26-35, 2023 Oct.
Article in English | MEDLINE | ID: mdl-37595762

ABSTRACT

Particle engineering technologies have led to the commercialization of new inhaled powders like PulmoSolTM or PulmoSphereTM. Such platforms are produced by spray drying, a well-known process popular for its versatility, thanks to wide-ranging working parameters. Whereas these powders contain a high drug-loading, we have studied a low-dose case, in optimizing the production of powders with two anti-asthmatic drugs, budesonide and formoterol. Using a Design of Experiments approach, 27 powders were produced, with varying excipient mixes (cyclodextrins, raffinose and maltodextrins), solution concentrations, and spray drying parameters in order to maximize deep lung deposition, measured through fine particle fraction (next generation impactor). Based on statistical analysis, two powders made of hydropropyl-ß-cyclodextrin alone or mixed with raffinose and L-leucine were selected. Indeed, the two powders demonstrated very high fine particle fraction (>55%), considerably better than commercially available products. Deep lung deposition has been correlated to very fine particle size and lower microparticles interactions shown by laser diffraction assays at different working pressures, and particle morphometry. Moreover, the two drugs would be predicted to deposit homogeneously into the lung according to impaction studies. Uniform delivery is fundamental to control symptoms of asthma. In this study, we develop carrier-free inhalation powders promoting very efficient lung deposition and demonstrate the high impact of inter-particular interactions intensity on their aerosolization behaviour.


Subject(s)
Budesonide , Respiratory Aerosols and Droplets , Powders , Raffinose , Administration, Inhalation , Particle Size , Dry Powder Inhalers , Aerosols
3.
Environ Technol ; : 1-13, 2023 Apr 05.
Article in English | MEDLINE | ID: mdl-36912280

ABSTRACT

Phosphorus (P) is an indispensable nutrient for agriculture. Recovery and recycling of phosphorus from waste streams is necessary to ensure a circular P economy and reduce dependence on disproportionately distributed mineral P resources. In this study, a new process called 'PULSE' is presented for the recovery of P from sewage sludge, which can handle high metal contents. The process involves drying of sludge prior to acidic leaching to overcome the challenge of solid-liquid separation at low pH and to reduce the overall material flows. Another key point of the process is the removal of metals using reactive extraction to obtain a high-quality product with good plant availability. Laboratory experiments were conducted to evaluate and select the best process options. A chemical equilibrium tool was developed to simulate the unit operations of the process for optimization. Dissolution of P from sludge depends on leaching pH and the fraction of inorganic P in the sludge. The maximum P leaching efficiency for the sludge used in the study was between 65 and 70%. Under the tested conditions, Fe, Cd, Cu, Hg, Pb, and Zn were successfully removed from the sludge leach liquor by reactive extraction. The recovered product has a nutrient mass fraction of about 51% that includes Ca, PO43-, Mg, and K. Pot trials confirmed that the agronomical efficiency of the product is comparable to that of triple superphosphate.

4.
Int J Pharm ; 613: 121319, 2022 Feb 05.
Article in English | MEDLINE | ID: mdl-34875354

ABSTRACT

Pulmonary drug administration has long been used for local or systemic treatment due to several advantages. Dry powder inhalers emerge as the most promising due to efficiency, ecologic, and drug stability concerns. Coarse lactose-carrier is still the gold standard when inhalation powders are developed. Despite some efforts to produce new types of powders, the lung drug deposition is still poorly controlled, which will ultimately impact therapeutic effectiveness. In this study, we developed "engineered-inhalation powders" using the spray-drying technique. Multiple carbohydrates excipients were binary mixed and combined with two active pharmaceutical ingredients for asthma therapy (budesonide and formoterol). Particle morphology, from spherical to deflated shapes, was characterized by the number and the depth of dimples measured from SEM images. We define a new characteristic deflation ratio ξ as the product between the number of dimples and their depth. Six different powders having opposite morphologies have been selected and we have demonstrated a linear correlation between the fine particle fraction and the deflation ratio of produced powders. Overall, we showed first that the morphology of inhalable powder can be finely tuned by spray-drying technique when excipients varied. Secondly, we developed stable inhalation powders that simultaneously induced high fine particle fractions (>40%) for two drugs due to their deflated surface. The stability has been evaluated for up to 2 months at room temperature.


Subject(s)
Excipients , Lactose , Aerosols , Particle Size , Powders
5.
Front Bioeng Biotechnol ; 9: 623701, 2021.
Article in English | MEDLINE | ID: mdl-33738277

ABSTRACT

Surfactin is a lipoheptapeptide produced by several Bacillus species and identified for the first time in 1969. At first, the biosynthesis of this remarkable biosurfactant was described in this review. The peptide moiety of the surfactin is synthesized using huge multienzymatic proteins called NonRibosomal Peptide Synthetases. This mechanism is responsible for the peptide biodiversity of the members of the surfactin family. In addition, on the fatty acid side, fifteen different isoforms (from C12 to C17) can be incorporated so increasing the number of the surfactin-like biomolecules. The review also highlights the last development in metabolic modeling and engineering and in synthetic biology to direct surfactin biosynthesis but also to generate novel derivatives. This large set of different biomolecules leads to a broad spectrum of physico-chemical properties and biological activities. The last parts of the review summarized the numerous studies related to the production processes optimization as well as the approaches developed to increase the surfactin productivity of Bacillus cells taking into account the different steps of its biosynthesis from gene transcription to surfactin degradation in the culture medium.

6.
Cancers (Basel) ; 11(2)2019 Feb 23.
Article in English | MEDLINE | ID: mdl-30813402

ABSTRACT

Multiple myeloma osteolytic disease is caused by an uncoupled bone-remodelling process with an increased osteoclast activity. Disease development relies on interactions between myeloma cells and bone marrow stromal cells. Recent findings suggest a role for glycan-binding proteins in myeloma microenvironment. Here, we investigated lectins involved in osteoclastogenesis and their role in myeloma bone disease. Microarray data analysis showed a lower expression of galectin-1 (gal-1) in mature osteoclasts compared to monocytic progenitor cells, confirmed at the RNA and protein levels in osteoclast cultures. Confocal microscopy showed that gal-1 localised predominantly in the sealing zone of mature osteoclasts. Although equal differentiated-osteoclast numbers, gal-1-/- osteoclasts showed a higher resorption activity compared to wild-type controls. Micro-computed tomography showed an aberrant bone phenotype with decreased bone densities in gal-1-/- mice. In vivo, tumour progression was faster in gal-1-/- mice and associated with a marked bone loss. Additionally, myeloma cells were found to decrease gal-1 expression in osteoclasts. Our results demonstrate that galectin-1 regulates osteoclast activity with an increased resorption by gal-1-/- osteoclasts and decreased bone densities in gal-1-/- mice. We observed an enhanced tumour development in gal-1-/- mice compared to wild-type mice, suggesting that galectin-1 has a functional role in stromal cells in myeloma microenvironment.

7.
Haematologica ; 103(8): 1359-1368, 2018 08.
Article in English | MEDLINE | ID: mdl-29748441

ABSTRACT

Multiple myeloma bone disease is characterized by an uncoupling of bone remodeling in the multiple myeloma microenvironment, resulting in the development of lytic bone lesions. Most myeloma patients suffer from these bone lesions, which not only cause morbidity but also negatively impact survival. The development of novel therapies, ideally with a combined anti-resorptive and bone-anabolic effect, is of great interest because lesions persist with the current standard of care, even in patients in complete remission. We have previously shown that MELK plays a central role in proliferation-associated high-risk multiple myeloma and its inhibition with OTSSP167 resulted in decreased tumor load. MELK inhibition in bone cells has not yet been explored, although some reports suggest that factors downstream of MELK stimulate osteoclast activity and inhibit osteoblast activity, which makes MELK inhibition a promising therapeutic approach. Therefore, we assessed the effect of OTSSP167 on bone cell activity and the development of myeloma-induced bone disease. OTSSP167 inhibited osteoclast activity in vitro by decreasing progenitor viability as well as via a direct anti-resorptive effect on mature osteoclasts. In addition, OTSSP167 stimulated matrix deposition and mineralization by osteoblasts in vitro This combined anti-resorptive and osteoblast-stimulating effect of OTSSP167 resulted in the complete prevention of lytic lesions and bone loss in myeloma-bearing mice. Immunohistomorphometric analyses corroborated our in vitro findings. In conclusion, we show that OTSSP167 has a direct effect on myeloma-induced bone disease in addition to its anti-multiple myeloma effect, which warrants further clinical development of MELK inhibition in multiple myeloma.


Subject(s)
Bone Diseases/drug therapy , Multiple Myeloma/drug therapy , Naphthyridines/pharmacology , Protein Serine-Threonine Kinases/antagonists & inhibitors , Animals , Bone Diseases/etiology , Cell Line , Cell Proliferation/drug effects , Female , Heterografts , Humans , Mice , Mothers , Multiple Myeloma/complications , Multiple Myeloma/pathology , Naphthyridines/therapeutic use , Osteoblasts/drug effects , Osteoclasts/drug effects , Osteolysis/drug therapy , Osteolysis/prevention & control , Protein Kinase Inhibitors/pharmacology , Protein Kinase Inhibitors/therapeutic use
8.
Oncotarget ; 7(21): 30712-29, 2016 May 24.
Article in English | MEDLINE | ID: mdl-27095574

ABSTRACT

Multiple myeloma (MM)-associated osteolytic bone disease is a major cause of morbidity and mortality in MM patients and the development of new therapeutic strategies is of great interest. The proto-oncogene SRC is an attractive target for such a strategy. In the current study, we investigated the effect of treatment with the SRC inhibitor saracatinib (AZD0530) on osteoclast and osteoblast differentiation and function, and on the development of MM and its associated bone disease in the 5TGM.1 and 5T2MM murine MM models. In vitro data showed an inhibitory effect of saracatinib on osteoclast differentiation, polarization and resorptive function. In osteoblasts, collagen deposition and matrix mineralization were affected by saracatinib. MM cell proliferation and tumor burden remained unaltered following saracatinib treatment and we could not detect any synergistic effects with drugs that are part of standard care in MM. We observed a marked reduction of bone loss after treatment of MM-bearing mice with saracatinib as reflected by a restoration of trabecular bone parameters to levels observed in naive control mice. Histomorphometric analyses support that this occurs through an inhibition of bone resorption. In conclusion, these data further establish SRC inhibition as a promising therapeutic approach for the treatment of MM-associated osteolytic bone disease.


Subject(s)
Benzodioxoles/therapeutic use , Multiple Myeloma/drug therapy , Osteolysis/drug therapy , Protein Kinase Inhibitors/therapeutic use , Proto-Oncogenes/drug effects , Quinazolines/therapeutic use , src-Family Kinases/antagonists & inhibitors , Administration, Oral , Animals , Bone and Bones/drug effects , Bone and Bones/pathology , Cell Differentiation/drug effects , Cell Line, Tumor , Disease Models, Animal , Female , Humans , Male , Mice , Mice, Inbred C57BL , Multiple Myeloma/complications , Multiple Myeloma/pathology , Osteoblasts/drug effects , Osteoclasts/drug effects , Osteolysis/etiology , Osteolysis/pathology , Proto-Oncogene Mas
9.
Waste Manag ; 50: 184-93, 2016 Apr.
Article in English | MEDLINE | ID: mdl-26898478

ABSTRACT

This paper undertakes an environmental evaluation of hybrid vehicles recycling, using industrial data from Comet Traitement SA in Belgium. Three business lines have been modelled and analysed. The first one is relative to the business as usual with a dismantling to recover batteries and engines followed by shredding and post shredding treatments. The second one considers, in addition, the removal of electronic control units (ECU) before shredding followed by same steps than in the first line and the last one is relative to the additional removal of big plastic parts before shredding and business as usual post shredding treatments. Results show non-significant environmental benefits when ECU or large parts of plastics are recovered before shredding. Improvements in terms of environmental benefits are lower than the uncertainty of the results. Indeed, the performing usual process for end-of-life vehicles (ELV) treatment reaches 97% of the ELV which is valorised in terms of metal and energy recoveries. Post shredding treatment units include metals, plastics and energy recovery of residues. Comet business as usual route for ELV valorisation is in accordance with the requirements of the European directive and recommendations for further improvement with dismantling of other parts (ECU or plastics) before shredding are non-relevant in this case.


Subject(s)
Electronic Waste/analysis , Industrial Waste/analysis , Plastics/analysis , Recycling/methods , Waste Management/methods , Automobiles , Belgium , Models, Theoretical , Refuse Disposal
10.
Water Res ; 91: 11-8, 2016 Mar 15.
Article in English | MEDLINE | ID: mdl-26773481

ABSTRACT

The effects of hydrothermal treatment on the drying properties of sludge were determined. Sludge was hydrothermally treated at 180-260 °C for 0.5-5 h using NaOH and HCl as additives to influence reaction conditions. Untreated sludge and attained hydrochar samples were then dried under identical conditions with a laboratory microdryer and an X-ray microtomograph was used to follow changes in sample dimensions. The effective moisture diffusivities of sludge and hydrochar samples were determined and the effect of process conditions on respective mean diffusivities evaluated using multiple linear regression. Based on the results the drying time of untreated sludge decreased from approximately 80 min to 37-59 min for sludge hydrochar. Drying of untreated sludge was governed by the falling rate period where drying flux decreased continuously as a function of sludge moisture content due to heat and mass transfer limitations and sample shrinkage. Hydrothermal treatment increased the drying flux of sludge hydrochar and decreased the effect of internal heat and mass transfer limitations and sample shrinkage especially at higher treatment temperatures. The determined effective moisture diffusivities of sludge and hydrochar increased as a function of decreasing moisture content and the mean diffusivity of untreated sludge (8.56·10(-9) m(2) s(-1)) and sludge hydrochar (12.7-27.5·10(-9) m(2) s(-1)) were found statistically different. The attained regression model indicated that treatment temperature governed the mean diffusivity of hydrochar, as the effects of NaOH and HCl were statistically insignificant. The attained results enabled prediction of sludge drying properties through mean moisture diffusivity based on hydrothermal treatment conditions.


Subject(s)
Desiccation , Hot Temperature , Sewage/chemistry , Waste Disposal, Fluid/methods , Charcoal/analysis , Models, Theoretical , X-Ray Microtomography
11.
Int J Oral Maxillofac Implants ; 28(2): 393-402, 2013.
Article in English | MEDLINE | ID: mdl-23527340

ABSTRACT

PURPOSE: Subsinus bone regeneration procedures are reliable and known to be effective with the use of biomaterials alone. Nevertheless, many types of biomaterials are available, and the efficacy of each in terms of bone formation and resorption rate has rarely been compared. This study aimed to compare bone formation, resorption rate, osteoconductivity, and three-dimensional volume changes of three biomaterials often used for alveolar ridge augmentation. MATERIALS AND METHODS: Rabbits underwent bilateral sinus elevation using three different types of space fillers: bovine hydroxyapatite (BHA), beta-tricalcium phosphate (ß-TCP), or biphasic calcium phosphate (BCP). Animals were sacrificed at 1 week, 5 weeks, and 6 months. Samples were subjected to microcomputed tomography and histologic examination. Qualitative analysis was performed on nondecalcified sections, and quantitative histomorphometric analysis was conducted using scanning electron microscopy. Volume differences in augmented bone were calculated at different time points. RESULTS: All three particulated biomaterials promoted osteogenesis in this particular animal model. At 6 months, biomaterial resorption rates were significantly different across the three groups. The highest resorption rate was found with ß-TCP, in which only 6.7% of the baseline particle surface remained. At 6 months, bone was in close contact with the BHA particles, constituting a composite network; in contrast, BCP particles were often surrounded by soft tissue. Within each group, no significant differences in volume were found at the different time points. CONCLUSIONS: Despite the limitations of the study, the three studied biomaterials proved to be effective in promoting osteogenesis. High resorption rates and complete replacement of the biomaterials by bone seemed to withstand intrasinusal pressure. Further investigations in humans should consider longer follow-up periods.


Subject(s)
Alveolar Ridge Augmentation/methods , Biocompatible Materials/pharmacology , Bone Resorption , Calcium Phosphates/pharmacology , Hydroxyapatites/pharmacology , Osteogenesis/drug effects , Animals , Bone Regeneration/drug effects , Bone Regeneration/physiology , Bone Resorption/physiopathology , Bone and Bones , Durapatite , Male , Microscopy, Electron, Scanning , Osteogenesis/physiology , Rabbits , Random Allocation , Time Factors , X-Ray Microtomography
12.
Clin Oral Implants Res ; 24(5): 505-11, 2013 May.
Article in English | MEDLINE | ID: mdl-22313247

ABSTRACT

AIM: The inclusion of biomaterial particles used for alveolar bone regeneration in a carrier or in binding agents such as collagen gel or fibers is of interest as a means to help with surgical handling. However, the possible influence of collagen on bone tissue response to biomaterials is poorly studied. The objective of the present study was to investigate, in a sub-sinus bone augmentation model in rabbits, the effect of collagen at different stages of the osteogenesis process. Histologic, histomorphometric and volumetric analyses were performed. MATERIALS AND METHODS: Rabbits underwent a double sinus lift procedure using bovine hydroxyapatite (BHA), collagenated bovine hydroxyapatite (BHAColl), and prehydrated and collagenated porcine hydroxyapatite (PHAColl). Animals were sacrificed at 1 week, 5 weeks or 6 months. Samples were subjected to X-ray micro-tomography and histology. Qualitative analysis was performed on the non-decalcified sections and quantitative histomorphometric analyses were conducted using scanning electron microscopy (SEM). Volume variations of bone augmentations were calculated at different time points. RESULTS: The three biomaterials allowed an optimal bone formation and were able to equally withstand sinusal reexpansion. A comparable percentage of new bone, as well as 3D volume stability, was found between the groups at each time point. However, the PHAColl resorption rate was significantly higher than the rates in other groups (P = 0.0003), with only 3.6% of the particles remaining at 6 months. At 1 week, both collagenated groups displayed the presence of inflammatory cells although BHA did not show any sign of inflammation. At 5 weeks and 6 months, the inflammatory process had disappeared completely in the BHAColl groups, whereas some inflammatory-like cells could still be observed around the remaining particles of PHAColl. CONCLUSIONS AND CLINICAL IMPLICATIONS: Within the limitations of this study in rabbits, the findings showed the presence of inflammatory-like cells at the early stage of bone regeneration when collagenated xenogenic biomaterials were used compared to xenogenic granules alone. Nevertheless, similar bone formation occurred and comparable 3D volumes were found at 6 months in the different groups.


Subject(s)
Bone Regeneration/physiology , Minerals/pharmacology , Sinus Floor Augmentation/methods , Animals , Durapatite/pharmacology , Male , Microscopy, Electron, Scanning , Rabbits , X-Ray Microtomography
13.
Clin Implant Dent Relat Res ; 15(3): 412-26, 2013 Jun.
Article in English | MEDLINE | ID: mdl-21815992

ABSTRACT

AIM: The first objective of this study was to qualitatively and quantitatively assess the bone formation process, particularly the long-term behavior and three-dimensional volume stability of subsinusal bone regeneration, using titanium (Ti) or bovine hydroxyapatite (BHA) granules, in a rabbit model. The second objective was to evaluate the effect of the hydration of the BHA particles with a therapeutic concentration of doxycycline solution on the osteogenesis and biomaterial resorption. MATERIALS AND METHODS: Rabbits underwent a double sinus lift procedure using one of three materials: grade 1 porous Ti particles, BHA, or BHA hydrated with doxycycline solution (0.1mg/ml) (BHATTC). Animals were sacrificed after 1 week, 5 weeks, or 6 months. Samples were analyzed using µCT and nondecalcified histology. RESULTS: The materials used in each of the three groups allowed an optimal bone formation; bone quantities and densities were not statistically different between the three groups. At 6 months, more stable three-dimensional volume stability was found with Ti and BHATTC (p=.0033). At 5 weeks and 6 months, bone to material contact corroborating osteoconduction was significantly higher with BHA and BHATTC than with Ti (p<.0001). CONCLUSIONS AND CLINICAL IMPLICATIONS: Even though the studied biomaterials displayed different architectures, they are relevant candidates for sinus lift bone augmentation prior to dental implants because they allow adequate three-dimensional stability and osteogenesis. However, to recommend the clinical use of Ti, both an observation on the drilling effects of Ti particles and clinical trials are needed.


Subject(s)
Biocompatible Materials/therapeutic use , Bone Regeneration/physiology , Bone Substitutes/therapeutic use , Durapatite/therapeutic use , Sinus Floor Augmentation/methods , Titanium/chemistry , Absorbable Implants , Animals , Anti-Bacterial Agents/therapeutic use , Biocompatible Materials/chemistry , Bone Density/physiology , Cattle , Doxycycline/therapeutic use , Image Processing, Computer-Assisted/methods , Imaging, Three-Dimensional/methods , Male , Maxillary Sinus/diagnostic imaging , Maxillary Sinus/pathology , Minerals/therapeutic use , Models, Animal , Osseointegration/physiology , Osteogenesis/physiology , Porosity , Rabbits , Random Allocation , Time Factors , X-Ray Microtomography/methods
14.
Clin Oral Implants Res ; 22(5): 538-45, 2011 May.
Article in English | MEDLINE | ID: mdl-21198906

ABSTRACT

AIM: The first objective of the present study was to compare the short- and long-term 3D volume stability of sub-sinusal bone regeneration in rabbits using different space fillers. The second objective was to assess qualitatively and quantitatively the early bone formation process and long-term behavior of the regenerated bone. MATERIALS AND METHODS: Fifteen rabbits underwent a double sinus lift procedure using: blood clot (Clot), autogenous bone chips (Auto) and bovine hydroxyapatite (BHA). Animals were euthanized at 1 week, 5 weeks and 6 months. Samples were subjected to X-ray microtomography and histology. Variations in the volume of bone augmentations were calculated at different time points. Qualitative analysis was performed using 7 µm sections and quantitative histomorphometric analyses were carried out using scanning electron microscopy. RESULTS: From baseline (100%) to 5 weeks, the augmented volumes declined to 17.3% (Clot), 57.6% (Auto) and 90.6% (BHA). After 6 months, only 19.4% (Clot) and 31.4% (Auto) of initial volumes were found, while it remained more stable in the BHA group (84%). At 1 week, an initial osteogenesis process could be observed in the three groups along the bone walls. At 5 weeks, despite a significant decline in the volume, newly formed bone density was higher with Clot and Auto than with BHA. At 6 months, bone densities were statistically similar in the three groups. However, after 6 months, the surface invaded by newly formed bone (regenerated area) was significantly higher when BHA was used as space filler. In the BHA group, the biomaterial area slightly decreased from 42.7% (1 week) to 40% (5 weeks) and 34.9% (6 months) and the density of the composite regenerated tissue (bone+BHA) reached >50% at 6 months. CONCLUSIONS AND CLINICAL IMPLICATIONS: The three space fillers allowed bone formation to occur. Nevertheless, augmented volumes declined in the Clot and Auto groups, while they remained stable with BHA. A slowly resorbable biomaterial might be suitable in sub-sinusal bone augmentation for preventing the re-expansion process and for augmenting the density of the regenerated tissues.


Subject(s)
Alveolar Ridge Augmentation/methods , Biocompatible Materials/therapeutic use , Blood Coagulation , Bone Substitutes/therapeutic use , Bone Transplantation/physiology , Durapatite/therapeutic use , Maxilla/surgery , Maxillary Sinus/surgery , Absorbable Implants , Animals , Bone Density/physiology , Bone Regeneration/physiology , Bone Remodeling/physiology , Bone Resorption/pathology , Cattle , Cone-Beam Computed Tomography , Imaging, Three-Dimensional , Male , Maxilla/pathology , Maxillary Sinus/pathology , Microscopy, Electron, Scanning , Minerals/therapeutic use , Osteoblasts/pathology , Osteoclasts/pathology , Osteogenesis/physiology , Rabbits , Time Factors , Transplantation, Autologous , X-Ray Microtomography
SELECTION OF CITATIONS
SEARCH DETAIL
...